United States: Biden Administration Proposes Biosimilar Substitution Without Interchangeability - Goodwin Procter LLP

The Biden Administration recently released a 2025 Budget Proposal which includes permitting biosimilar substitution without the Food and Drug Administration's ("FDA")...